Highlight
– Subthalamic nucleus deep brain stimulation (STN-DBS) produces durable motor improvement in Parkinson disease (PD) over five years.
– STN-DBS significantly suppresses dyskinesia and improves activities of daily living without medication.
– A stable 28% reduction in levodopa-equivalent dose is maintained throughout five years.
– Treatment shows a favorable safety profile, with infections as the most common serious adverse event.

Hi there, just became aware of your blog through Google, and found that it is truly informative. I am gonna watch out for brussels. I’ll appreciate if you continue this in future. Lots of people will be benefited from your writing. Cheers!
Your house is valueble for me. Thanks!…